Press Releases

Confirmed by Legal Opinions from Nationally Recognized Law Firms Bethesda, Maryland, December 19, 2011 — After obtaining confirmatory opinions from multiple experts in patent law, Northwest Biotherapeutics (OTC.BB: NWBO) (NW Bio) today reaffirms that its lead program, applying DCVax®-L for treatment of brain cancer, continues to have clear freedom to operate with respect to US Patent 7,939,090 (the ‘090 patent), recently issued to... Read More

Removes $31.5 Million Of Liabilities Bethesda, Maryland, December 2, 2011 — Northwest Biotherapeutics (OTC.BB: NWBO) (Northwest Bio) announced today that it has implemented a major clean-up of its balance sheet, removing $31.5 million of liabilities through settlement, retirement and conversion. This restructuring reduces the Company’s liabilities from $48 million at the end of the third quarter to $16.5 million. Only about $2.3... Read More

$2.4 Million Immediate Funding and Agreement to Purchase First $3 Million of New Shares Under Pending Equity Facility BETHESDA, MD, November 17, 2011 — Northwest Biotherapeutics (OTC.BB: NWBO) (Northwest Bio) today announced $2.4 million in new funding under favorable loan terms, as well as an agreement to purchase the first $3 million in shares of common stock under the previously announced agreement for an equity facility of up to... Read More

Premier Gathering of Neuro-Oncology Specialists from Across the US and Abroad Multiple Company Initiatives During Four-Day Meeting BETHESDA, MD, November 15, 2011 — Northwest Biotherapeutics (OTC.BB: NWBO) (Northwest Bio) today announced that it will participate in the annual meeting of the Society of NeuroOncology (SNO) to be held at the Hyatt Regency, Orange County, California from November 17-20. SNO is the premier professional... Read More

Describes DCVax® Science and Company’s Progress BETHESDA, MD, November 1, 2011 — Northwest Biotherapeutics (OTC.BB: NWBO) (Northwest Bio) today announced, as part of its program of public outreach and education, the availability online of an interview of Northwest Bio Chairman and CEO Linda Powers by CEO/CFO Publication. The interview describes in layman’s terms both the encouraging science behind DCVax® and the progress... Read More